QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 2 filers reported holding QIAGEN NV in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,835 | -10.1% | 70 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $3,152 | -2.0% | 70 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $3,215 | -16.3% | 70 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $3,840 | +28.0% | 70 | -9.1% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | -25.0% | 77 | -15.4% | 0.00% | 0.0% |
| Q2 2022 | $4,000 | 0.0% | 91 | +21.3% | 0.00% | 0.0% |
| Q1 2022 | $4,000 | 0.0% | 75 | +13.6% | 0.00% | 0.0% |
| Q4 2021 | $4,000 | +100.0% | 66 | +57.1% | 0.00% | +200.0% |
| Q3 2021 | $2,000 | -33.3% | 42 | -20.8% | 0.00% | -50.0% |
| Q2 2021 | $3,000 | 0.0% | 53 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $3,000 | +50.0% | 53 | +60.6% | 0.00% | 0.0% |
| Q4 2020 | $2,000 | 0.0% | 33 | -17.5% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | +100.0% | 40 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $1,000 | 0.0% | 40 | -23.1% | 0.00% | 0.0% |
| Q4 2019 | $1,000 | – | 52 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
| Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
| Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
| Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
| RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
| SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
| FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
| Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
| Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |